Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(4R)-DELTA1-pyrroline-4-hydroxy-2-carboxylate + NADPH + H+
(4R)-4-hydroxy-L-proline + NADP+
-
-
-
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
1-pyrroline-(4R)-hydroxy-2-carboxylate + NADPH + H+
(4R)-hydroxy-L-proline + NADP+
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
-
-
-
?
cis-3-hydroxy-L-proline + NADP+
? + NADPH + H+
low activity
-
-
r
cis-4-hydroxy-L-proline + NADP+
? + NADPH + H+
low activity
-
-
r
DELTA1-piperideine 2-carboxylate + NADH + H+
L-pipecolate + NAD+
-
-
-
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
DELTA1-piperidine-2-carboxylate + NADH + H+
L-pipecolate + NAD+
DELTA1-piperidine-2-carboxylate + NADPH + H+
L-pipecolate + NADP+
DELTA1-pyrroline-(4R)-hydroxy-2-carboxylate + NADPH + H+
(4R)-hydroxy-L-proline + NADP+
-
-
-
r
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
DELTA1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
DELTA1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
DELTA2-thiazoline-2-carboxylate + NADPH + H+
? + NADP+
-
-
-
?
L-pipecolate + NAD(P)+
1-piperideine-2-carboxylate + NAD(P)H + H+
-
-
-
r
L-pipecolate + NAD+
DELTA1-piperidine-2-carboxylate + NADH + H+
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NADPH + H+
L-pipecolic acid + NAD(P)+
DELTA1-piperidine-2-carboxylate + NAD(P)H
-
at 26% of the rate with L-proline
-
-
r
L-proline + NAD(P)+
1-pyrroline-2-carboxylate + NAD(P)H + H+
-
-
-
r
L-proline + NAD(P)+
DELTA1-pyrroline-2-carboxylate + NAD(P)H + H+
-
-
-
-
r
L-proline + NAD+
DELTA1-pyrroline-2-carboxylate + NADH + H+
L-proline + NADP+
DELTA1-pyrroline-2-carboxylate + NADPH + H+
trans-4-hydroxy-L-proline + NADP+
? + NADPH + H+
low activity
-
-
r
additional information
?
-
1-piperideine-2-carboxylate + NAD(P)H + H+

L-pipecolate + NAD(P)+
-
-
-
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
-
-
-
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+

L-proline + NAD(P)+
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
-
-
-
r
1-pyrroline-2-carboxylate + NADH + H+

L-proline + NAD+
-
-
-
?
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
-
-
-
r
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
-
-
-
r
DELTA1-piperideine 2-carboxylate + NADPH + H+

L-pipecolate + NADP+
-
-
-
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H

L-pipecolic acid + NAD(P)+
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
Cercocebus sp.
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
r
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NADH + H+

L-pipecolate + NAD+
-
-
-
r
DELTA1-piperidine-2-carboxylate + NADH + H+
L-pipecolate + NAD+
-
-
-
r
DELTA1-piperidine-2-carboxylate + NADPH + H+

L-pipecolate + NADP+
-
-
-
r
DELTA1-piperidine-2-carboxylate + NADPH + H+
L-pipecolate + NADP+
-
-
-
r
DELTA1-pyrroline-2-carboxylate + NAD(P)H

L-proline + NAD(P)+
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
Cercocebus sp.
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
at 55% of the rate with DELTA1-piperidine-2-carboxylate
-
-
r
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NADH + H+

L-proline + NAD+
-
-
-
r
DELTA1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
-
-
r
DELTA1-pyrroline-2-carboxylate + NADPH + H+

L-proline + NADP+
-
-
-
r
DELTA1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
-
-
-
r
L-pipecolate + NAD+

DELTA1-piperidine-2-carboxylate + NADH + H+
-
-
-
r
L-pipecolate + NAD+
DELTA1-piperidine-2-carboxylate + NADH + H+
-
-
-
r
L-pipecolate + NADP+

DELTA1-piperidine-2-carboxylate + NADPH + H+
-
-
-
r
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NADPH + H+
-
-
-
r
L-proline + NAD+

DELTA1-pyrroline-2-carboxylate + NADH + H+
-
-
-
r
L-proline + NAD+
DELTA1-pyrroline-2-carboxylate + NADH + H+
-
-
-
r
L-proline + NADP+

DELTA1-pyrroline-2-carboxylate + NADPH + H+
-
-
-
r
L-proline + NADP+
DELTA1-pyrroline-2-carboxylate + NADPH + H+
-
-
-
r
additional information

?
-
trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
-
-
?
additional information
?
-
-
trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
-
-
?
additional information
?
-
no activity with trans-4-hydroxy-D-proline, D-proline, trans-3-hydroxy-L-proline, cis-4-hydroxy-D-proline, and cis-3-hydroxy-D-proline, poor activity with trans-4-hydroxy-L-proline
-
-
?
additional information
?
-
-
no activity with trans-4-hydroxy-D-proline, D-proline, trans-3-hydroxy-L-proline, cis-4-hydroxy-D-proline, and cis-3-hydroxy-D-proline, poor activity with trans-4-hydroxy-L-proline
-
-
?
additional information
?
-
reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
-
-
-
additional information
?
-
-
reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
-
-
-
additional information
?
-
purified recombinant human CRYM possesses substantial KR activity. Ketimine reductase is a typical imine reductase. Substrate specificity of recombinant human ketimine reductase (KR) toward DELTA1-piperideine-2-carboxylate (P2CR) and various noncyclized imine intermediates, overview. N-methyl-L-alanine is produced when human KR is incubated in the presence of methylamine, NADPH and pyruvate. Human KR catalyzes the reductive alkylamination of phenylpyruvate and glyoxylate in the presence of methylamine. Substrate docking
-
-
-
additional information
?
-
-
purified recombinant human CRYM possesses substantial KR activity. Ketimine reductase is a typical imine reductase. Substrate specificity of recombinant human ketimine reductase (KR) toward DELTA1-piperideine-2-carboxylate (P2CR) and various noncyclized imine intermediates, overview. N-methyl-L-alanine is produced when human KR is incubated in the presence of methylamine, NADPH and pyruvate. Human KR catalyzes the reductive alkylamination of phenylpyruvate and glyoxylate in the presence of methylamine. Substrate docking
-
-
-
additional information
?
-
-
involved in the catabolism of D-lysine and D-proline
-
-
?
additional information
?
-
-
reverse reactions oxidizing L-proline or L-pipecolic acid are catalyzed at much lower rates. Very poor substrates: trans-4-hydroxy-L-proline, L-thioproline
-
-
?
additional information
?
-
-
the enzyme from kidney shows no activity with DELTA1-pyrroline-5-carboxylate and DELTA1-piperideine-6-carboxylate
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
1-pyrroline-2-carboxylate + NADH + H+
L-proline + NAD+
-
-
-
?
1-pyrroline-2-carboxylate + NADPH + H+
L-proline + NADP+
-
-
-
?
DELTA1-piperideine 2-carboxylate + NADH + H+
L-pipecolate + NAD+
-
-
-
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
DELTA2-thiazoline-2-carboxylate + NADPH + H+
? + NADP+
-
-
-
?
additional information
?
-
1-piperideine-2-carboxylate + NAD(P)H + H+

L-pipecolate + NAD(P)+
-
-
-
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
-
-
-
r
1-piperideine-2-carboxylate + NAD(P)H + H+
L-pipecolate + NAD(P)+
-
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+

L-proline + NAD(P)+
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
-
-
-
r
1-pyrroline-2-carboxylate + NAD(P)H + H+
L-proline + NAD(P)+
-
-
-
-
r
DELTA1-piperideine 2-carboxylate + NADPH + H+

L-pipecolate + NADP+
-
-
-
?
DELTA1-piperideine 2-carboxylate + NADPH + H+
L-pipecolate + NADP+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H

L-pipecolic acid + NAD(P)+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
Cercocebus sp.
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
?
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
ir
DELTA1-piperidine-2-carboxylate + NAD(P)H
L-pipecolic acid + NAD(P)+
-
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H

L-proline + NAD(P)+
-
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
Cercocebus sp.
-
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
?
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
ir
DELTA1-pyrroline-2-carboxylate + NAD(P)H
L-proline + NAD(P)+
-
-
-
-
ir
additional information

?
-
trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
-
-
?
additional information
?
-
-
trans-3-hydroxy-L-proline is converted to proline by the purified LhpH and LhpI proteins, i.e. trans-3-hydroxy-L-proline dehydratase and DELTA1-pyrroline-2-carboxylate reductase, at pH 7.0. LhpI has dual metabolic functions as a reductase for DELTA1-pyrroline-2-carboxylate and DELTA1-piperidine-2-carboxylate
-
-
?
additional information
?
-
reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
-
-
-
additional information
?
-
-
reciprocal relationship between thyroid hormone binding and DELTA1-piperideine-2-carboxylate (P2C) binding to ketimine reductase
-
-
-
additional information
?
-
-
involved in the catabolism of D-lysine and D-proline
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
African Swine Fever
African Swine Fever Virus Protein E199L Promotes Cell Autophagy through the Interaction of PYCR2.
Brain Diseases
Loss of PYCR2 Causes Neurodegeneration by Increasing Cerebral Glycine Levels via SHMT2.
Carcinogenesis
Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Carcinoma, Hepatocellular
Molecular cloning of cDNA encoding a 55-kDa multifunctional thyroid hormone binding protein of skeletal muscle sarcoplasmic reticulum.
Carcinoma, Hepatocellular
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Carcinoma, Squamous Cell
An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate.
Carcinoma, Squamous Cell
Characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein by use of monoclonal antibodies.
Choriocarcinoma
Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein.
Colonic Neoplasms
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Cutis Laxa
Genetic analysis of Pycr1 and Pycr2 in mice.
Deafness
CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
Deafness
mu-crystallin, a NADPH-dependent T(3)-binding protein in cytosol.
Deafness
Spiking Expression of mu-Crystallin mRNA during Treatment with Methimazole in Patients with Graves' Hyperthyroidism.
Glioblastoma
Biomarker discovery: a proteomic approach for brain cancer profiling.
Hearing Loss
CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.